deferasirox
Showing 51 - 75 of 114
Thalassemia Major Trial (Taurine, Placebo)
Not yet recruiting
- Thalassemia Major
- Taurine
- Placebo
- (no location specified)
Feb 28, 2020
Transfusional Iron Overload, ß-thalassemia Major, Pediatric Rare Anemia Trial in France, Italy (Deferasirox)
Completed
- Transfusional Iron Overload
- +2 more
- Deferasirox
-
Lyon, France
- +3 more
Feb 12, 2017
MDS, Beta-Thalassemia Trial in Hungary (deferasirox)
Completed
- Myelodysplastic Syndromes
- Beta-Thalassemia
- deferasirox
-
Budapest, Hungary
- +3 more
Feb 22, 2017
High Risk MDS Trial in United States (Azacitidine, Azacitidine plus Deferasirox)
Terminated
- High Risk MDS
- Azacitidine
- Azacitidine plus Deferasirox
-
Little Rock, Arkansas
- +5 more
Mar 6, 2017
Beta-Thalassemia, Hemosiderosis Trial in Worldwide (deferasirox)
Completed
- Beta-Thalassemia
- Hemosiderosis
- deferasirox
-
Cairo, Egypt
- +4 more
Feb 28, 2017
Hemochromatosis, MDS Trial in Bergen (Deferasirox, Venesection)
Terminated
- Hemochromatosis
- Myelodysplastic Syndromes
- Deferasirox
- Venesection
-
Bergen, NorwayHaukeland University Hospital, Clinical Trial Unit
Jan 20, 2017
Chronic Iron Overload Due to Transfusion-dependant Anemias Trial in Worldwide (Deferasirox dispersible tablet, Defearisox
Completed
- Chronic Iron Overload Due to Transfusion-dependant Anemias
- Deferasirox dispersible tablet
- Defearisox film-coated tablet
-
Orange, California
- +50 more
Jul 22, 2017
Beta Thalassemia Transfusion Dependent Trial in Cagliari, Orbassano (Deferasirox)
Completed
- Beta Thalassemia Transfusion Dependent
- Deferasirox
-
Cagliari, Italy
- +1 more
Dec 8, 2016
Myelodysplastic Syndrome With Low-grade Lesions, Iron Overload Due to Repeated Red Blood Cell Transfusions Trial in Tel Hashomer
Completed
- Myelodysplastic Syndrome With Low-grade Lesions
- Iron Overload Due to Repeated Red Blood Cell Transfusions
-
Tel Hashomer, IsraelChim Sheba Medical Center
Oct 30, 2018
AL-Hijama in Thalassmia Major Trial in Tanta (Al-hijamah, Deferasirox)
Unknown status
- AL-Hijama in Thalassmia Major
- Al-hijamah
- Deferasirox
-
Tanta, Gharbia, Egypt
- +1 more
Apr 24, 2017
Myelodysplastic Syndrome, Transfusional Iron Overload Trial in Worldwide (Deferasirox)
Terminated
- Myelodysplastic Syndrome
- Transfusional Iron Overload
- Deferasirox
-
Caen, Cedex, France
- +9 more
Mar 1, 2017
Myelodysplastic Syndrome, Thalassemia Trial in Moscow, Saint-Petersburg, St. Petersburg (Deferasirox)
Completed
- Myelodysplastic Syndrome
- Thalassemia
- Deferasirox
-
Moscow, Russian Federation
- +2 more
Dec 8, 2016
Hemoglobinopathies, MDS, Other Inherited or Acquired Anaemia Trial in Australia (deferasirox)
Completed
- Hemoglobinopathies
- +6 more
- deferasirox
-
Adelaide, Australia
- +3 more
Feb 20, 2017
Acute Myeloblastic Leukemia and Myelodysplastic Syndrome
Unknown status
- Myeloid Leukemia
- Myelodysplastic Syndromes
-
Pierre-Bénite, FranceCentre Hospitalier Lyon Sud
Sep 3, 2018
Iron Overload Trial in Leipzig (Deferasirox)
Completed
- Iron Overload
- Deferasirox
-
Leipzig, GermanyNovartis Investigative Site
Nov 16, 2016
Anemia, Sickle Cell, Transfusion Hemosiderosis Trial in Los Angeles (deferasirox)
Terminated
- Anemia, Sickle Cell
- Transfusion Hemosiderosis
- deferasirox
-
Los Angeles, CaliforniaChildrens Hospital Los Angeles
Dec 15, 2016
Iron Mediated Vascular Disease in Sickle Cell Anemia Patients
Completed
- Sickle Cell Disease
-
Los Angeles, CaliforniaChildren's Hospital Los Angeles
Jan 9, 2019
MDS, Hemosiderosis Trial in Italy (Deferasirox)
Completed
- Myelodysplastic Syndromes
- Hemosiderosis
- Deferasirox
-
Alessandria, Italy
- +16 more
Nov 21, 2016
Iron Overload After Hematopoietic Stem Cell Transplantation (HSCT) in Patients With Beta-thalassemia Major Trial in Turkey
Completed
- Iron Overload After Hematopoietic Stem Cell Transplantation (HSCT) in Patients With Beta-thalassemia Major
-
Ankara, Turkey
- +5 more
Sep 12, 2016
Beta-Thalassemia, Iron Overload Trial in Toronto (Amlodipine, Deferasirox)
Unknown status
- Beta-Thalassemia
- Iron Overload
- Amlodipine
- Deferasirox
-
Toronto, Ontario, CanadaUniversity Health Network
Oct 24, 2016
Anemia, Sickle Cell Trial in United States (ICL670, deferoxamine)
Completed
- Anemia, Sickle Cell
- ICL670, deferoxamine
-
Mobile, Alabama
- +33 more
Aug 18, 2017
Descriptive Epidemiology on Management of Mucormycosis
Completed
- Mycoses
-
New Delhi, Delhi, India
- +12 more
Feb 8, 2018
Acute Myeloid Leukemia, Acute Lymphoid Leukemia Trial (Cytarabine, Deferasirox)
Unknown status
- Acute Myeloid Leukemia
- Acute Lymphoid Leukemia
- Cytarabine
- Deferasirox
- (no location specified)
Feb 24, 2016
Thalassemia Trial in Karachi (Standard Chelation, Amlodipine)
Completed
- Thalassemia
- Standard Chelation
- Amlodipine
-
Karachi, Sindh, PakistanAga Khan University Hospital
Jun 28, 2017